Kewaunee Scientific’s CEO Cashes In on Stock Sale!

New insider activity at Kewaunee Scientific ( (KEQU) ) has taken place on September 22, 2025.

President & CEO Thomas David III Hull has recently sold 1,425 shares of Kewaunee Scientific stock, amounting to a total value of $65,039.

Recent Updates on KEQU stock

In recent developments, Kewaunee Scientific Corporation appointed J. Jette Campbell to its Board of Directors, aiming to leverage his expertise in financial restructuring and business strategy to accelerate growth and expand its global presence. The company reported a significant increase in Q1 revenue to $71.1 million from $48.3 million the previous year, despite challenging market conditions due to uncertain government policies and evolving tariff structures. CEO Thomas Hull III highlighted the company’s focus on both organic and inorganic growth, with strategic investments in people, processes, and technology, although these investments may pressure near-term earnings growth. Analysts have maintained a positive outlook on Kewaunee, supported by strong financial performance, reasonable valuation, and bullish technical indicators, though caution is advised due to potential market corrections. The company’s strategic moves, including the recent acquisition of NuAire, are expected to enhance its market presence.

Spark’s Take on KEQU Stock

According to Spark, TipRanks’ AI Analyst, KEQU is a Neutral.

Kewaunee Scientific’s overall stock score is primarily influenced by its solid financial performance, which is offset by bearish technical indicators. The stock’s undervaluation offers potential upside, but the lack of dividend yield and negative market momentum are significant concerns.

To see Spark’s full report on KEQU stock, click here.

More about Kewaunee Scientific

YTD Price Performance: -29.78%

Average Trading Volume: 14,381

Technical Sentiment Signal: Hold

Current Market Cap: $126.1M